Clinical Trial Update: RVU120 (SEL120) in Patients with Relapse/Refractory Metastatic or Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes RVU120 (SEL120) being tested in Phase 1/2 for patients with advanced, relapsed or refractory solid tumors, with the study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• RVU120 (SEL120)

Snippet

Sponsor: Ryvu Therapeutics SA | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING